Coalition Letter: Clarification of Eligibility for Small Businesses with Equity Investors under the SBA’s 7(a) Loan Program within the CARES Act

Global & Trade

Global Medical Technology Alliance: Open letter to the G-20 Heads of State and Government: Need to collaborate to open global trade in response to COVID-19

Regulatory Affairs

AdvaMed® Letter to FDA: Letter to Owen Faris RE Clinical Trials Flex Proposals

“Dear Governor” Letter from 8 national health care products trade groups

Legal / Value-Based Collaborations

May 8, 2019 AdvaMed® Letter Refining Value-Based Safe Harbor Proposals

Legal / Value-Based Collaborations

AdvaMed® Statement on Health Care Innovation Caucus RFI Regarding Value-Based Arrangements

Diagnostics / Regulatory Affairs

AdvaMedDx® Letter to Sen. Alexander and Murray and Rep. Walden and Pallone

Legal / Value-Based Collaborations

AdvaMed® 2018 AKS Safe Harbor Proposals For Value-Based Arrangements

Legal / Physicians Payment Sunshine Act / Value-Based Collaborations

AdvaMed® 2017 AKS Safe Harbor Proposals For Value-Based Arrangements

Regulatory Affairs

FDA Response Letter to AdvaMed®’s UDI Cross Reference Proposal

FDA sent this letter in response to issues AdvaMed® raised to the FDA regarding implementation of the UDI rule.